Dateline Chicago: MRA and GRACE Immunotherapy Forum
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 October 2014 In Events, Science, Treatment
On Sunday October 26, MRA and its partner GRACE (Global Resource for Advancing Cancer Education) held a forum for patients/caregivers with melanoma, kidney cancer and lung cancer at the Intercontinental Hotel in downtown Chicago. Despite the fact that it was a gorgeous day outside—warm and sunny for Chicago in late...
Turning the Tide Against Cancer Through Sustained Medical Innovation
Guest Blog Contributors Edward Abrahams, Ph.D., President, Personalized Medicine Coalition Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer, American Association for Cancer Research Marcia A. Kean, M.B.A., Chairman, Feinstein Kean Healthcare We live in extraordinary times.
Expanded Access Programs: A Time of Amazement in Melanoma
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 August 2014 In Science, Treatment
For those of you keeping a close eye on the field of melanoma treatments, you know that we find ourselves living in a simply amazing period of opportunity and innovation—even though there is still a long way to go.
Immunotherapy & Awareness: Fighting Melanoma on Two Fronts
23 August 2014 In Melanoma Stories
MRA is saddened by the news that Mark Carter lost his battle with melanoma this week. We send our condolences to his family and friends. He had hoped that sharing his story would educate and raise awareness of this deadly disease.
An Outdoor Enthusiast’s Guide to Playing It Sun Safe
Johnie Gall || DirtbagDarling.com
Melanoma Awareness From a High Schooler’s Perspective: Where We Are and Where We Need To Be
19 July 2014 In Melanoma Stories
Not many teenagers know that melanoma is the number one new cancer diagnosed in young adults ages 25-29. It is also difficult to believe that as with many mistakes made at a young age, neglecting sun safety during childhood and adolescence can harm you later in life.
Ready. Set. May!
3 May 2014 In News
Melanoma Awareness Month is here and we've got tons in store this month. Check out MRA's new video "Progress for Patients" below. If you like it, share it! And don't forget to celebrate Melanoma Monday on May 5th by engaging with MRA on social media! [youtube url=http://www.youtube.com/watch?v=5my5tR5SzxU]USA Today offers...
The First FDA Approval of Two Melanoma Therapies in Combination
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 10 January 2014 In News
You may have heard this from other sources already, but we want to take a minute and explain why we’re so excited at MRA by some recent news. This week, GlaxoSmithKline announced that it had received approval from the U.S. Food and Drug Administration (FDA) of a combination treatment for melanoma.
Adjuvant Therapy Advocacy ASCO Awareness Board Members BRAF Cancer Combination Therapy Detection FDA Grants Immunotherapy Melanoma microbiome MRA Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Research Science Social Media Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People